Delivery Order SPE2DR25D2014-SPE2DR26FA2E0
- Not listed
- The Defense Logistics Agency awarded a $18,473.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials on January 7, 2026, with a completion date of January 8, 2026. The place of performance is located in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet federal procurement requirements through open competition. AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a $16,653.15 delivery order to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials. This non-set-aside, competitively awarded contract carries a firm fixed price structure with an ultimate completion date of January 2, 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and serves as a major healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Injectafer 750 mg/15 ml vials with a ceiling value of $21,388.96. This non-set-aside, firm fixed price delivery order is scheduled for completion by December 4, 2025, with fulfillment based at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $4,260.48 to supply Injectafer 750 mg/15 mL vials. The order, issued on December 18, 2025, with completion targeted for December 19, 2025, represents a firm fixed price delivery under a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, fulfilled this requirement as part of its federal pharmaceutical supply portfolio serving military and veteran...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,265.22 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials. This firm fixed-price contract, issued on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a non-set-aside competitive award to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a $21,873.30 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Injectafer 750 mg/15 ml vials. This firm fixed-price, competitively awarded contract is scheduled for completion by August 11, 2025, with performance based in Conshohocken, Pennsylvania. The award represents a non-set-aside procurement, indicating AmerisourceBergen competed against other vendors to secure this pharmaceutical supply delivery. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $12,066.50 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials. This competitive award, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $10,913.07 to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Injectafer 750 mg/15 ml vials. This competitively awarded, firm fixed-price contract contains no set-aside designation and is scheduled for completion by December 24, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,239.00 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by July 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The delivery order represents...
- The Defense Logistics Agency awarded a delivery order valued at $13,394.81 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials. This firm fixed-price, competitively awarded delivery order was issued on June 18, 2025, with an ultimate completion date of June 20, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a straightforward pharmaceutical procurement to support federal medical supply needs, with no...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA2E0Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,051.08 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 mL vials on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a single task order under AmerisourceBergen's larger relationship with the federal government for pharmaceutical supply. This delivery order operates under AmerisourceBergen Drug Corp's parent company, Cencora, Inc., which holds a substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. This broader IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products, medical devices, and healthcare commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor, AmerisourceBergen maintains a critical role in the federal medical supply chain and regularly fulfills procurement requirements across multiple therapeutic domains for defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.1k | 1/11/26 |